Clinical Trial Update: Rifaximin Use in Severe Alcoholic Hepatitis [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial evaluating rifaximin for severe alcoholic hepatitis; current status is not disclosed in the provided snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Hepatitis

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Saint Vincent's Hospital, Korea | Conditions: Severe Alcoholic Hepatitis | Phase 3 | Status: UNKNOWN